10:34 AM EDT, 10/25/2024 (MT Newswires) -- TC BioPharm ( TCBP ) said Friday it is compliant with all Nasdaq listing requirements and that its shares will continue to trade on the exchange.

The company refuted a social media claim posted earlier this week and denied being in any danger of delisting from the exchange.

Shares of the company were down 4% in recent trading.

Price: 1.90, Change: -0.08, Percent Change: -4.04